ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 113237 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 113237; 2) Community: the network communities that were significantly associated with the response to NSC 113237; 3) Molecule: the relationships between components within communities and NSC 113237; 4) MDR: the compounds that were significantly associated with the NSC 113237.

NSC Compound Enrichment Correlation
NSC 722877 Null 0.0171439890681608 0.40144632
NSC 731805 Null 0.0171439890681608 0.37505413
NSC 740564 6-(3-Aminopropyl)-9-fluoro-5,6-dihydro-2,3-dimethoxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0171439890681608 0.46895582
NSC 752331 (Z)-6-(2-(pyridin-2-ylmethylene)hydrazinyl)-9H-purine-9-beta-D-riboside 0.0171439890681608 0.36935345
NSC 754081 7-(4-methoxybenzyl)-4,4-dimethyl-6-phenyl-5,7-dihydro-4H-isoxazolo[5,4-e]isoindole 0.0171439890681608 0.33706819
NSC 756134 GSK1023156A 0.0171439890681608 0.31649876
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.0181211508101519 0.53702769
NSC 169774 Bromocriptine methanesulfonate 0.0181211508101519 0.34890552
NSC 291330 Null 0.0181211508101519 0.35628844
NSC 317908 Null 0.0181211508101519 0.33850674
Total:136  Current:73    [First] [Prev] [Next] [Last]